Cocaine use in Europe - a multi-centre study: patterns of use in different groups by Prinzleve, M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2004
Cocaine use in Europe - a multi-centre study: patterns of use in different
groups
Prinzleve, M; Haasen, C; Zurhold, H; Matali, J L; Bruguera, E; Gerevich, J; Bácskai, E; Ryder, N;
Butler, S; Manning, V; Gossop, M; Pezous, A; Verster, A; Camposeragna, A; Andersson, P; Olsson, B;
Primorac, A; Fischer, G; Güttinger, F; Rehm, J; Krausz, M
Abstract: AIM The study investigates patterns of cocaine powder and crack cocaine use of different
groups in nine European cities. DESIGN, SETTING, PARTICIPANTS Multi-centre cross-sectional study
conducted in Barcelona, Budapest, Dublin, Hamburg, London, Paris, Rome, Vienna, and Zurich. Data
were collected by structured face-to-face interviews. The sample comprises 1,855 cocaine users out of
three subgroups: 632 cocaine users in addiction treatment, mainly maintenance treatment; 615 socially
marginalized cocaine users not in treatment, and 608 socially integrated cocaine users not in treatment.
MEASUREMENTS Use of cocaine powder, crack cocaine and other substances in the last 30 days, routes
of administration, and lifetime use of cocaine powder and crack cocaine. FINDINGS The marginalized
group showed the highest intensity of cocaine use, the highest intensity of heroin use and of multiple
substance use. 95% of the integrated group snorted cocaine powder, while in the two other groups,
injecting was quite prevalent, but with huge differences between the cities. 96% of all participants had
used at least one other substance in addition to cocaine in the last 30 days. CONCLUSIONS The
use of cocaine powder and crack cocaine varies widely between different groups and between cities.
Nonetheless, multiple substance use is the predominating pattern of cocaine use, and the different routes
of administration have to be taken into account.
DOI: 10.1159/000079835
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-97869
Published Version
Originally published at:
Prinzleve, M; Haasen, C; Zurhold, H; Matali, J L; Bruguera, E; Gerevich, J; Bácskai, E; Ryder, N;
Butler, S; Manning, V; Gossop, M; Pezous, A; Verster, A; Camposeragna, A; Andersson, P; Olsson, B;
Primorac, A; Fischer, G; Güttinger, F; Rehm, J; Krausz, M (2004). Cocaine use in Europe - a multi-
centre study: patterns of use in different groups. European Addiction Research, 10(4):147-155. DOI:
10.1159/000079835
Research Report
Eur Addict Res 2004;10:147–155
DOI: 10.1159/000079835
Cocaine Use in Europe – A Multi-Centre
Study: Patterns of Use in Different
Groups
Michael Prinzlevea Christian Haasena Heike Zurholda Josep Lluis Matalib
Eugeni Bruguerab Jo´zsef Gerevichc Erika Ba´cskaic Niamh Ryderd
Shane Butlerd Victoria Manninge Michael Gossope Anne-Marie Pezousf
Annette Versterg Antonella Camposeragnag Pia Anderssonh
Börje Olssonh Andjela Primoraci Gabriele Fischeri Franziska Güttingerj
Jürgen Rehmj Michael Krausza
aZentrum für Interdisziplinäre Suchtforschung der Universität Hamburg, Germany; bUnidad Docente de la
Universidad Autonoma de Barcelona, Spain; cDrogalapı´tva´ny Budapest, Hungary; dAddiction Research Centre,
Trinity College Dublin, Ireland; eNational Addiction Centre, Institute of Psychiatry London, UK;
fDepartment of Psychiatry, Lariboisiere Hospital, Paris, France; gCentro Studi Compartimenti Additivi Roma, Italy;
hCentre for Social Research on Alcohol and Drugs Stockholm, Sweden; iUniversity of Vienna,
Department of Psychiatry, Out-Patient Drug Addiction, Vienna, Austria; jAddiction Research Institute,
Zurich University, Institut für Suchtforschung, Zurich, Switzerland
Michael Prinzleve
Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg ZIS
Klinik für Psychiatrie und Psychotherapie des UKE
Martinistrasse 52, DE–20246 Hamburg (Germany)
Tel. +49 40 42803 7901, Fax +49 40 42803 8351, E-Mail prinzleve@uke.uni-hamburg.de
ABC
Fax + 41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2004 S. Karger AG, Basel
1022–6877/04/0104–0147$21.00/0
Accessible online at:
www.karger.com/ear
Key Words
Cocaine powder W Crack cocaine W Consumption patterns
Abstract
Aim: The study investigates patterns of cocaine powder
and crack cocaine use of different groups in nine Euro-
pean cities. Design, Setting, Participants: Multi-centre
cross-sectional study conducted in Barcelona, Budapest,
Dublin, Hamburg, London, Paris, Rome, Vienna, and
Zurich. Data were collected by structured face-to-face
interviews. The sample comprises 1,855 cocaine users
out of three subgroups: 632 cocaine users in addiction
treatment, mainly maintenance treatment; 615 socially
marginalized cocaine users not in treatment, and 608
socially integrated cocaine users not in treatment. Mea-
surements: Use of cocaine powder, crack cocaine and
other substances in the last 30 days, routes of adminis-
tration, and lifetime use of cocaine powder and crack
cocaine. Findings: The marginalized group showed the
highest intensity of cocaine use, the highest intensity of
heroin use and of multiple substance use. 95% of the
integrated group snorted cocaine powder, while in the
two other groups, injecting was quite prevalent, but with
huge differences between the cities. 96% of all partici-
pants had used at least one other substance in addition
to cocaine in the last 30 days. Conclusions: The use of
cocaine powder and crack cocaine varies widely be-
tween different groups and between cities. Nonetheless,
multiple substance use is the predominating pattern of
cocaine use, and the different routes of administration
have to be taken into account.
Copyright © 2004 S. Karger AG, Basel
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Introduction
Against the background of rising figures of cocaine use
in Europe, a multi-centre study was carried out to define
target group specific recommendations in order to im-
prove the specific care for cocaine and crack users [Haa-
sen et al., this issue]. One part of this multi-method study
was a user investigation, i.e. quantitative interviews with
cocaine users to analyse their consumption behaviour,
social and health status and support needs.
Evidence so far suggests that cocaine is used in differ-
ent drug using groups in Europe. Accordingly, given the
importance of contextual factors for substance use in gen-
eral, it may be assumed that patterns of cocaine use vary
across different subgroups, and therefore are accompa-
nied by different consequences of use. Hence, in the con-
sumer investigation three different subgroups of cocaine
users were recruited, each seen as relevant with respect to
cocaine use. One group consisted of cocaine users who are
treated in a drug-specific setting, mainly outpatient main-
tenance treatment, since a number of studies have shown
that concurrent abuse of cocaine is widespread in metha-
done patients [1–3]. The second group consisted of social-
ly marginalized drug users who belong to the ‘old’ drug
scene of heroin users and who are outside a drug specific
treatment. In this group, an increasing use of cocaine has
been observed in recent years [4, 5]. Socially integrated
drug users who are using cocaine mainly in recreational
contexts constituted the third target group, since cocaine
use in this group seems to play an important role as a part
of an occasional use, e.g. at dance events or ‘raves’ [6].
In addition to taking different users groups into ac-
count, the distinction between cocaine hydrochloride, or
cocaine powder, and crack cocaine is of central impor-
tance with respect to the patterns of cocaine use. Crack
cocaine is associated with different sequences or progres-
sions of use [7, 8], different routes of administration and
subsequent degrees of abuse liability and propensity for
dependence [9, 10], different users groups [11, 12], and
different treatment outcomes [13, 14].
Hence, the analyses presented here mainly focus on
two aspects: (1) differences in the consumption behaviour
between the different groups of cocaine users, and (2) dif-
ferences between the use of cocaine powder and crack
cocaine.
Methods
Design
In each participating city, cocaine and crack users from three dif-
ferent subgroups were recruited: 70 cocaine/crack users in drug treat-
ment, mainly maintenance treatment; 70 socially marginalized co-
caine/crack users outside a drug specific treatment, and 70 socially
integrated cocaine/crack users not in a drug-specific treatment.
The three target groups were recruited at specific locations suit-
able to access the respective groups. The treatment group was
recruited mainly in out-patient maintenance clinics or, if not possi-
ble, in other (inpatient or outpatient) addiction treatment settings.
The marginalized group was recruited at places where drug users
usually meet to sell, buy or use drugs, or in the surroundings of low-
threshold addiction facilities, e.g. needle exchange programmes or
safe injection rooms. The integrated group was recruited at different
party places, e.g. discos, nightclubs or pubs, or through private con-
tacts. To exclude an overlap between the three target groups, each
centre determined specific recruitment locations, i.e. treatment facil-
ities and places typically attended by the two other groups.
Besides affiliation to the respective target group, the inclusion cri-
terion was a use of cocaine powder or crack cocaine at least once in
the last month. The three target groups were recruited according to a
criterion-oriented sample strategy: They were recruited consecu-
tively until 70 cocaine and crack consumers were included into each
subsample (n = 210 for each centre). Subjects at the determined
recruitment locations were first asked with regard to the inclusion
criteria. If these were met and after the subject gave informed con-
sent, the interview took place. After the interview, the participants
received 10 Euro or a respective compensation fee.
Measures 
Structured face-to-face interviews were conducted to assess the
consumption behaviour, social and health status. The instrument
used was an adjusted version of the Maudsley Addiction Profile
MAP [15]. Besides, self-ratings were used to assess the dependence
upon cocaine using the Severity of Dependence Scale SDS [16], the
treatment motivation by means of Transtheoretical Model-based
instruments [17, 18], and the present treatment and service utilisa-
tion behaviour, which all will be analyzed in future manuscripts.
The MAP is a brief, interviewer-administered questionnaire that
measures problems in four domains: substance use, health-risk
behaviour, personal/social functioning, and physical and psychologi-
cal health. The MAP was extended with items concerning the pat-
terns, and the history of cocaine and crack use, the number of drug-
or alcohol-specific treatments, and some items concerning the social
situation. All instruments and a user manual following the original
manual [19] were provided in English or in German. If necessary,
they were translated into the respective language and, as a control,
back-translated.
Data on substance use was assessed according to the total number
of days of use within the last 30 days, and the routes of administra-
tion. In case of more than one route of administration, the most
severe was recorded. In addition to the current drug use data, lifetime
data assessed according to the EuropASI [20] was reported for
cocaine powder and crack cocaine.
Subjects 
Because of the low prevalence of cocaine in Stockholm [Haasen et
al., this issue], it was not possible to recruit a sufficient number of
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cocaine users who met the inclusion criterion of having used cocaine
powder or crack cocaine at least once in the past month. Therefore,
the following analysis is based on data from nine European cities.
The total number of subjects is 1,855, with 34% belonging to the
treatment group, 33% to the marginalized group, and 33% to the
integrated group. There are small deviations from the originally
intended sample size of 70 cocaine users in each group and each city:
for the marginalized group in Dublin (n = 73), Paris (n = 74), London
(n = 57) and Zurich (n = 61), for the integrated group in Dublin (n =
51) and Paris (n = 67), for the treatment group in Dublin (n = 71) and
Paris (n = 71).
As regards the recruitment places the subjects were in general
recruited as intended. In the treatment group, 81% were recruited in
maintenance clinics, 9% in other drug treatment services. The mar-
ginalized group was mainly recruited in low-threshold facilities
(58%), on the drug scene (16%), or via snowballing (10%). The inte-
grated group was recruited mainly at night-life sites (38%) or via
snowballing (40%) and the rest (17%) at different medical services or
public places.
Procedure 
In this paper, the main focus of the statistical analyses is on a
comparison between the target groups. Additionally, major differ-
ences between cities within each target group are mentioned. Only
established statistical procedures were used. The comparison of fre-
quencies was done by means of ¯ 2 test. For the comparison of means,
only nonparametric techniques were used (Kruskal-Wallis test,
Mann-Whitney test), because the distribution of values of all vari-
ables under examination in this paper was not normal.
For the comparison between the target groups, differences be-
tween each pair of means were analyzed using an adjusted signifi-
cance level of p ! 0.01, for the comparison between subgroups within
each target group the significance level was p ! 0.001.
Results
Sample Characteristics
Thirty-two percent of the 1,855 participants were fe-
male. The highest proportion of females (37%) was found
in the integrated group, followed by the marginalized
group (31%) and the treatment group (28%). The propor-
tion of females varied widely between the cities, ranging
from less than 20% in Barcelona and Paris to 40% and
more in London and Dublin.
The average age of the whole sample was 30.8 (B 7.4)
years, ranging from 16 to 62 years. On average, males
(31.7 B 7.5 years) were 3 years older than females (28.8 B
6.6 years), and the treatment group (33.1 B 7.6 years) was
older than the marginalized group (31.3 B 7.0 years),
which again was older than the integrated group (27.9 B
6.5 years).
The distinction between the marginalized group and
the integrated group was primarily based on the degree of
social integration, or disintegration, respectively. And, as
expected, there were significant differences between the
target groups, and these differences were pointing in the
expected direction with the lowest degree of social inte-
gration in the marginalized group. Twenty-one percent of
the marginalized group had lived in unstable living ar-
rangements in the past 12 months, compared to 2% in the
integrated group and 10% in the treatment group. The
marginalized group showed the highest rate of current
unemployment (74%, integrated group: 18%; treatment
group: 67%), and only 34% indicated no criminal activi-
ties in the past 30 days prior to the interview, while this
was true for 58% in the integrated group, and 50% in
treatment group. On the other hand, these results cannot
disguise that a substantial minority of those classified as
socially marginalized in fact seemed to live in a relatively
good social situation as regards living arrangements, em-
ployment, and the possibility to abstain from criminal
activities.
Use of Cocaine Powder and Crack Cocaine
In total, 86% of all subjects had used cocaine powder in
the past 30 days prior to the interview, 27% had used
crack cocaine. The comparison between the three sub-
groups as a whole shows that as expected the use of
cocaine powder was highest in the marginalized group,
followed by the treatment group, which again used more
frequently than the integrated group. For crack cocaine,
the differences were in the same direction and again sig-
nificant between the three groups (table 1).
On the other hand, the differences especially between
the treatment group and the marginalized group were,
although statistically significant, not as marked as ex-
pected. One explanation for this was the different preva-
lence of powder cocaine and crack cocaine, respectively
(fig. 1). The prevalence of cocaine powder use was com-
paratively low in the marginalized group in Paris, London
and Hamburg, and in London and Paris in the treatment
group as well. On the other hand, in these three cities
crack cocaine played an important role in terms of a high
prevalence in the treatment group and in the marginalized
group. In the integrated group, in 5 of the 9 cities a small
number of crack cocaine users was found, but in general
the use of cocaine powder was predominating in all of the
nine cities.
As figure 1 also indicates, a small number of subjects
used cocaine powder as well as crack cocaine. The use of
only one form of cocaine was the most frequent, and in
total 73% used cocaine powder alone, and 14% used crack
cocaine alone. But in sum 12% currently used crack
cocaine as well as cocaine powder, 40% of them belonging
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Table 1. Substance use: days with use in the last 30 days by target group
Substance Target group
treatment
(n = 632)
mean SD
marginalized
(n = 615)
mean SD
integrated
(n = 608)
mean SD
¯2 p
Cocaine powder 11.2a, b 11.1 13.9 a, c 12.6 7.0b, c 6.7 32.1 !0.001
Crack cocaine 5.5a, b 10.2 7.9 a, c 11.8 0.2b, c 1.7 231.91 !0.001
Alcohol 9.6a, b 12.0 7.3a, c 10.5 13.8b, c 9.8 167.38 !0.001
Heroin 8.6a, b 11.7 15.0a, c 13.6 1.0b, c 4.8 513.67 !0.001
Non-presc. methadone 1.5a, b 5.7 1.8a, c 5.4 0.1b, c 1.3 112.7 !0.001
Non-presc. medication 6.7a, b 10.7 4.6a, c 9.0 1.1b,c 4.6 167.43 !0.001
Amphetamines 0.9a, b 3.9 1.1a, c 4.1 1.8b,c 3.3 230.81 !0.001
Cannabis 11.4a 12.6 10.8b 12.3 15.0a, b 12.5 44.72 !0.001
Hallucinogens 0.3a 2.8 0.5b 3.2 0.6a, b 1.8 112.18 !0.001
Inhalants 0.0a 0.1 0.1b 1.3 0.2a, b 1.4 41.96 !0.001
Means in a row sharing the same superscript letter differ significantly at p ! 0.01 (Mann-Whitney tests).
to the treatment group, 47% to the marginalized group
and 13% to the integrated group.
Accordingly, when looking at the differences between
the target groups, the different prevalence of crack co-
caine and the different patterns of use have to be taken
into account. This was done using the maximum number
of days with use of either cocaine powder or crack
cocaine. Then, the marginalized group used cocaine on
20.3 (B 10.7) days, whereas the treatment group has used
on 15.7 (B 11.0) days (Z = –7.47, p ! 0.001). Due to the
very low prevalence of crack cocaine in the integrated
group, the values here did not change remarkably (7.0 B
6.7 days).
For the use of cocaine in general, the proportion of reg-
ular users was computed, with a use of more than two
times per week as the criterion for regular use. Results
show that only 37% of the integrated group used cocaine
regularly, compared to 66% of the treatment group and
81% of the marginalized group (¯2(2) = 261.54, p ! 0.001).
This pattern, i.e. highest proportion of regular users in the
marginalized group followed by the treatment group and
lowest frequency in the integrated group, was found in 7
of the 9 cities, except Zurich, where a higher proportion of
regular users was found in the treatment group than in the
marginalized group (76 vs. 69%), and in Budapest with
the highest proportion of regular users in the treatment
group (94%) followed by the integrated group (69%) and
the lowest proportion in the marginalized group (43%).
Routes of Cocaine Administration 
In principle, all routes of administration were found,
but the oral use was only practiced by 7 subjects, 2 out of
the treatment group, 3 out of the marginalized group and
2 out of the integrated group. Within the integrated group,
the predominant route of administration of cocaine
powder was snorting, which was practiced by 95% of all
cocaine powder users in this group. Four percent were
smoking or chasing cocaine powder in this group, and 2%
were injecting. There were only marginal differences be-
tween the cities within this group, and the lowest preva-
lence of snorting cocaine powder was found in Paris with
88%.
There were no differences in the routes of administra-
tion between the two other groups (¯2(2) = 2.04, p = 0.361).
In each case about 60% of the cocaine powder users were
injecting (treatment: 58%; marginalized: 61%), about one
third were snorting (treatment: 36%; marginalized: 32%),
and 5% in the treatment group and 6% in the marginal-
ized group were smoking or chasing cocaine powder.
Although very similar at first sight, the routes of adminis-
tration differed markedly between the cities. In Budapest
about 90% of cocaine powder users in both treatment and
marginalized group were snorting, whereas in Dublin,
Hamburg, Vienna, and Zurich, injecting was the predom-
inant route of using cocaine powder, with rates ranging
from 70% in Hamburg to 84% in Zurich for the treatment
group, and from 65% in Zurich to 99% in Vienna for the
marginalized group. In Barcelona, Paris and Rome, about
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Fig. 1. 30-day prevalence of cocaine powder
and crack cocaine by target group and city.
50% of the cocaine powder users in the treatment group
were injecting, but snorting was also quite common with
rates of about 40%. Snorting was even more frequent than
injecting in the marginalized groups in Paris (48 vs. 32%)
and Rome (57 vs. 30%), whereas in Barcelona 97% of the
cocaine users in the marginalized group were injecting.
About 90% of the crack cocaine users were smoking,
about 10% were injecting. Injecting crack cocaine was
largely restricted to Paris and London, and in each case
both to the treatment group and the marginalized group.
For those who had used cocaine powder as well as crack
cocaine (n = 230), in general two groups of users with
respect to the application mode were found. Forty-four
percent of the parallel users were injecting cocaine powder
and smoking crack cocaine, 37% were smoking crack
cocaine and snorting cocaine powder. A pattern of using
one application mode for both forms was only found for
7% (smoking) and 5% (injecting). But there was a strong
relationship between injecting cocaine powder and inject-
ing heroin. Seventy-eight percent of the cocaine powder
injectors had used heroin as well. The very small group of
those injecting crack cocaine (n = 49) had a prevalence of
heroin use of 59%.
Lifetime Use of Cocaine Powder and Crack Cocaine
Only 7% in both treatment group and marginalized
group stated no regular lifetime cocaine use (period of at
least 6 months with regular use), while this was true for
29% in the integrated group (¯2(2) = 171.85, p ! 0.001).
The proportion of those within the integrated group, who
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indicated no regular lifetime use varied extremely be-
tween the cities. While in Dublin 82% of the integrated
group reported no regular use, this was the case for only
6% in Budapest. Rates of about 40% were found in Bar-
celona, Hamburg and Paris, rates between about 10 and
20% in London, Rome, Vienna and Zurich.
For those, who had had a period of regular lifetime use
of cocaine, there were differences between the three
groups in the years of use (¯2(2) = 77.33, p ! 0.001), but not
in the age of initiation. Here, the minimum value for the
age of initiation and the maximum value for the years of
use of either cocaine powder or crack cocaine were used.
For all three target groups, the age of initiation of regular
cocaine use was between 22 and 23 years on average
(treatment: 22.8 B 6.5 years; marginalized: 22.3 B 6.3
years; integrated: 22.9 B 5.4 years), whereas the years of
regular use differed between the integrated group (4.3 B
3.6 years) on the one hand, and both treatment group (6.7
B 5.2 years; p ! 0.01) and marginalized group (6.9 B 5.6
years; p ! 0.01) on the other.
In general, regular crack cocaine use started later than
the regular use of cocaine powder. The mean age of initia-
tion of those, whose only lifetime use was regular use of
cocaine powder (n = 1,126), was 22.6 (B 6.0) years, and
this was about 3 years earlier than the mean age of initia-
tion of those (n = 163) with a regular use of crack cocaine
only, who started at 25.8 (B 7.5) years (Z = –5.13, p !
0.001). Of all participants, 15% (n = 282) reported a regu-
lar lifetime use of both cocaine powder and crack cocaine.
The mean age of initiation here was 21.2 (B 5.2) years for
cocaine powder, and the regular use of crack cocaine
started about 4 years later at 25.1 (B 6.8) years (Z =
–10.18, p ! 0.001). In this group, only 9% started to use
cocaine powder regularly after they already had begun
using crack cocaine, while about two thirds started crack
cocaine use later than the use of cocaine powder and
about a quarter started using both forms at about the same
age. Half of those with a regular lifetime use of both
cocaine powder and crack were still using both forms,
while one third were only using crack cocaine, and 17%
only cocaine powder in the last 30 days.
Use of Other Substances 
Sixty-nine percent of all cocaine users had also used
cannabis, 67% had used alcohol in the last 30 days prior to
the interview. Forty-four percent currently used heroin,
32% non-prescribed medication, and 23% amphet-
amines. Non-prescribed methadone was used by 11%,
hallucinogens by 10%, and inhalants by 2%.
Alcohol use was highest in the integrated group, fol-
lowed by the treatment group, and lowest in the marginal-
ized group (table 1). The integrated group also used can-
nabis significantly more often than both treatment group
and marginalized group. The predominating substance in
the marginalized group was heroin. The marginalized
group also used non-prescribed medication (mainly ben-
zodiazepines) quite often, but less frequently than the
treatment group. The use of amphetamines, non-pre-
scribed methadone, hallucinogens and inhalants was very
low in all the groups, and not more frequent than two days
on average in each target group. Again, there were huge
differences between the cities. However, despite the dif-
ferences between the target groups, and within the target
groups between the cities, the overall consumption pat-
tern was multiple substance use. Ninety-six percent of all
participants had used at least one other substance in addi-
tion to cocaine powder or crack cocaine in the last 30
days.
Differences between Cocaine Powder and Crack
Cocaine 
Finally, data were analysed with respect to differences
in the consumption patterns between cocaine powder and
crack cocaine users. Since the prevalence of crack cocaine
was very low in the integrated group, this analysis was
restricted to the treatment group and the marginalized
group, and because of the differences between these target
groups, the data were analysed separately for each target
group. Due to the importance of the routes of administra-
tion, the group of those using only cocaine powder was
divided up into two subgroup, those injecting cocaine
powder and those using cocaine powder by non-injecting
modes, i.e. snorting, smoking or orally. Hence, for each of
the two target groups under examination, four subgroups
were created: non-injecting cocaine powder users, which
represented 27% of the treatment group and 23% of the
marginalized group, injecting cocaine powder users (treat-
ment 39%, marginalized 36%), crack cocaine users (treat-
ment 19%, marginalized 24%) and parallel users, i.e.
those who currently used both delivery systems (treat-
ment 15%, marginalized 17%). There were no differences
between the two target groups as regards the proportion
between these subgroups (¯2(3) = 6.84, p = 0.077).
In each target group, the most outstanding differences
between the cocaine consumption groups were found for
the use of cocaine in general, heroin and multiple sub-
stance use (fig. 2).
In both the treatment and marginalized group, the
non-injecting cocaine powder group showed a lower in-
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Fig. 2. Cocaine, heroin and multiple sub-
stance use: days with use in the last 30 days
by cocaine consumption group for treatment
and marginalized group. Cocaine refers to
the maximum number of days with use of
either cocaine powder or crack cocaine, mul-
tiple substance use to the number of days
with use of more than one substance.
tensity (p ! 0.001) of cocaine, heroin and multiple sub-
stance use, compared to the three other groups, which at
the same time showed similar pattern of use. The only
exception was a higher heroin use in the injecting cocaine
powder group compared to the crack cocaine group and
the group of parallel users.
Discussion
Within the framework of a multi-centre and multi-
method study on treatment needs of cocaine users in
Europe, data from 1855 cocaine users out of three differ-
ent subgroups were gathered in nine European cities. The
analyses presented in this paper outline the first evalua-
tion of data concerning the current and lifetime use, and
routes of administration of cocaine as well as the use of
other substances, and the central focus was on the differ-
ences between the three subgroups on the one hand, and
the differences between cocaine powder and crack co-
caine, on the other.
In the group of socially integrated cocaine users, the
majority was snorting cocaine powder, while crack co-
caine only played a very marginal role in this group. Over-
all, nearly one third in this group had never used cocaine
regularly, and currently about two thirds were using
cocaine irregularly. Hence, compared to the two other
groups, the integrated group showed the least problematic
cocaine use. For the other two groups, i.e. for socially mar-
ginalized cocaine users and cocaine users in a specific
addiction treatment, the results were at first sight quite
similar. Despite statistically significant differences in the
frequency of cocaine powder and crack cocaine use be-
tween both groups, these differences may not be clinically
relevant, and no differences were found for the overall
comparison of the routes of administration and the life-
time use of cocaine. These results seem to indicate that
the distinction between these two target groups does not
apply for cocaine use in general, and both groups more or
less seem to belong to the same group of ‘drug users’. But a
closer look at the data for the different cities revealed
marked differences between these two groups as regards
the prevalence rates of cocaine powder and crack cocaine
and the routes of administration.
When the different prevalence of crack cocaine was
taken into account and the two forms of cocaine were not
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separated, the differences between the treatment group
and the marginalized group became more evident, indi-
cating a clearly higher intensity of cocaine use in the mar-
ginalized group. As regards the routes of administration,
the overall similarity disguised the marked differences
between the cities, and the two groups, respectively, and
the most important factor for injecting cocaine powder
seems to be the use of heroin rather than belonging to the
treatment group or the marginalized group. So, taking
into consideration the use of cocaine in general, the use of
heroin and the multiple substance use, the marginalized
group showed the most problematic consumption pattern
in terms of the highest intensity of cocaine use, the highest
intensity of heroin use and of multiple substance use.
This is not to say that the treatment group’s substance
use data need no further considerations. The treatment
group showed a substantial cocaine use, and to a lower
degree and with differences between the cities, of other
substances as well, which first of all indicates the need for
a re-evaluation of their treatment. This was to be ex-
pected, considering that the treatment group was in fact in
treatment because of their heroin use, and considering the
evidence from the international literature which shows
that cocaine use by methadone patients often compro-
mises treatment [21–23].
Despite the differences between the target groups, and
within the target groups between the cities, multiple sub-
stance use was the predominating use pattern. Even if
alcohol was excluded from the analysis, only a minority
had exclusively used cocaine. In contrast to the preva-
lence of multiple substance use, this issue is only seldom
addressed in research. Although there is a growing aware-
ness that the use of only one psychotropic substance is the
exception and that multiple substance use is the rule, the
respective theoretical and empirical knowledge is scarce,
and there is an urgent need for research dealing with this
topic [24].
As regards the differences between cocaine powder and
crack cocaine, the data first of all indicates that consid-
ering the fear of an epidemic spread of crack cocaine as in
the USA [25], the use of crack cocaine obviously has not
spread into socially integrated user groups, and even with-
in socially disintegrated groups seems to be restricted to
some regions in Europe. Hence, the use of crack cocaine
has to be considered on a local or regional level, which is
confirmed by the results of other national studies showing
that even within one country the use of crack cocaine is
often restricted to some cities or regions [26–29]. In those
European countries with a relevant prevalence of crack
cocaine, cocaine powder was the ‘earlier’ form of cocaine,
and crack cocaine was introduced later. In line with this,
in the present sample the use of crack cocaine started lat-
er, and only a minority of those with a history of using
both forms started with crack cocaine. Currently, a small
group was still using crack cocaine as well as cocaine
powder, the majority of them either injecting cocaine
powder and smoking crack cocaine, or smoking crack
cocaine and snorting cocaine powder. Little is known
about this group, its size and the reasons for using both
forms by means of different routes of administration,
since most studies – if at all – distinguish between cocaine
powder and crack cocaine without presenting data con-
cerning the parallel use.
The analysis of the patterns of use of different groups
revealed that the consumption profiles of those who used
crack cocaine as well as cocaine powder, those who used
only crack cocaine and those who were injecting cocaine
powder were quite similar, and differed from those who
were using cocaine powder by non-injecting modes, with
the latter showing a comparatively less problematic con-
sumption pattern. This confirms the high importance of
the routes of administration of cocaine powder, and at the
same time shows that the dominating public discussion
about the differences between cocaine powder and crack
cocaine disguises the differences within the group of
cocaine powder users.
Finally, there have to be some remarks concerning the
sample strategy. While most of the results presented here
are in line with the expected differences between the three
target groups, others raise questions about the appro-
priateness of the distinction between them. This may be
due to different situations in the participating cities, but it
may also be a result of varying degrees of difficulties to
recruit cocaine users for such a study, which may have
lead to diverging recruitment strategies. Anyhow, future
analyses of the data in hand will have to consider whether
creating other subgroups is more appropriate to describe
differences between cocaine users in Europe.
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